ukrain

01/01/2000 - "The aim of this study was to compare the efficacy of different Ukrain doses in the combined treatment of 75 patients with breast cancer. "
01/01/1998 - "The aim of this study was to evaluate the efficacy of different doses of Ukrain in the treatment of 75 breast cancer patients. "
01/01/1998 - "Evaluation of the efficacy of Ukrain in the treatment of breast cancer: clinical and laboratory studies."
01/01/2000 - "Comparison of the efficacy of different doses of Ukrain in the combined treatment of breast cancer."
01/01/1996 - "The studies were carried out on material obtained from ten patients with breast cancer, treated preoperatively with Ukrain. "

12/01/2011 - "Monotherapy with Ukrain was more effective in mice with high-metastasizing tumors. "
01/01/1992 - "Clinical studies of Ukrain in terminal cancer patients (phase II)."
01/01/2020 - "NSC‑631570 (Ukrain) is an aqueous extract of Chelidonium majus, a herbaceous perennial plant, one of two species in the genus Chelidonium, which has been demonstrated to selectively kill tumor cells without affecting non‑malignant cells. "
09/01/2013 - "The aim of the work was to investigate the effect of NSC631570, a cancer-selective drug that is known to selectively accumulate in the tumor tissue, on hypoxic macrophage function. "
12/01/2012 - "Ukrain administration (12.5 mg/kg) led to significant inhibition of 4T07 tumor growth in vivo and sustained protective anti-tumor immunity following secondary challenge. "

06/01/2002 - "Efficacy of ukrain in the treatment of pancreatic cancer."
06/01/2002 - "This monocentric study evaluated the effect of ukrain in the treatment of pancreatic cancer. "
01/01/2000 - "The aim of this study was to investigate the effects of Ukrain in the treatment of pancreatic cancer. "
10/01/2012 - "Pancreatic cancer cells retain the epithelial-related phenotype and modify mitotic spindle microtubules after the administration of ukrain in vitro."
01/01/2010 - "Ukrain affects pancreas cancer cell phenotype in vitro by targeting MMP-9 and intra-/extracellular SPARC expression."

01/01/1998 - "The aim of the present study was to evaluate the efficacy of Ukrain as a new treatment modality in 28 patients with stage T1N0M0 bladder cancer. "
01/01/2000 - "The examination was carried out before and after Ukrain treatment (10 mg i.v./day, for 20 days), which was combined with systemic chemotherapy for bladder cancer. "
01/01/1998 - "Ukrain therapy of stage T1N0M0 bladder cancer patients."
01/01/1998 - "Ukrain, at a total dose from 100-300 mg as neoadjuvant therapy in patients with T1N0M0 bladder cancer, resulted in either complete or partial regression of tumors in 60.7 +/- 9.2% of cases. "
01/01/2000 - "The aim of this study was to elucidate the mechanisms of the anticancer effect of Ukrain by comparing the processes of formation of the pool of free amino acids and their derivatives in the blood plasma and tumor biopsy specimens and unchanged bladder tissue in 28 patients with T1N0M0 bladder cancer. "

12/01/2011 - "The therapeutic efficacy of NSC-631570 used in combination with PAM was more expressed in mice with low-metastasizing melanoma. "
07/01/2010 - "The results can be useful to optimize the regimen of mono and combined treatment of melanoma with Ukrain."
07/01/2010 - "Melanoma cells with high-metastatic properties were more sensitive to Ukrain than their low metastatic variants. "
07/01/2010 - "Treatment of melanoma cells with Ukrain resulted in apoptosis induction in a dose dependent manner. "
07/01/2010 - "To carry out comparative investigation of the effect of Ukrain used alone and in combination with pathogen associated molecules (PAM) on mitotic cycle and apoptosis induction in mouse melanoma cell lines with different biological properties. "